Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.10 EUR
−11.32 M EUR
37.43 M EUR
34.08 M
About NORDHEALTH AS
Sector
Industry
CEO
Charles William MacBain
Website
Headquarters
Helsinki
Founded
2021
ISIN
NO0011002651
FIGI
BBG011BN4507
Nordhealth AS is a cloud-based healthcare software-as-a-service company. It offers products including Provet Cloud and Diarium, both are cloud-based practice management software for veterinarians and therapists. It operates through the Veterinary and Therapy segments. The company was founded by Janne Heikki Huttunen in 2001 and is headquartered in Helsinki, Finland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6E5 is 3.29 EUR — it has increased by 2.81% in the past 24 hours. Watch NORDHEALTH AS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange NORDHEALTH AS stocks are traded under the ticker 6E5.
6E5 stock has risen by 6.82% compared to the previous week, the month change is a 1.54% rise, over the last year NORDHEALTH AS has showed a 64.50% increase.
We've gathered analysts' opinions on NORDHEALTH AS future price: according to them, 6E5 price has a max estimate of 3.92 EUR and a min estimate of 3.92 EUR. Watch 6E5 chart and read a more detailed NORDHEALTH AS stock forecast: see what analysts think of NORDHEALTH AS and suggest that you do with its stocks.
6E5 stock is 6.47% volatile and has beta coefficient of 1.44. Track NORDHEALTH AS stock price on the chart and check out the list of the most volatile stocks — is NORDHEALTH AS there?
Today NORDHEALTH AS has the market capitalization of 266.25 M, it has decreased by −0.55% over the last week.
Yes, you can track NORDHEALTH AS financials in yearly and quarterly reports right on TradingView.
NORDHEALTH AS is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
NORDHEALTH AS revenue for the last quarter amounts to 10.40 M EUR, despite the estimated figure of 10.10 M EUR. In the next quarter, revenue is expected to reach 10.70 M EUR.
6E5 net income for the last quarter is −805.68 K EUR, while the quarter before that showed −1.61 M EUR of net income which accounts for 49.92% change. Track more NORDHEALTH AS financial stats to get the full picture.
No, 6E5 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 29, 2024, the company has 395.00 employees. See our rating of the largest employees — is NORDHEALTH AS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NORDHEALTH AS EBITDA is 1.61 M EUR, and current EBITDA margin is −10.50%. See more stats in NORDHEALTH AS financial statements.
Like other stocks, 6E5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NORDHEALTH AS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NORDHEALTH AS technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NORDHEALTH AS stock shows the buy signal. See more of NORDHEALTH AS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.